EXAS logo

Exact Sciences (EXAS) EBIT

annual EBIT:

-$1.00B-$826.86M(-466.30%)
December 31, 2024

Summary

  • As of today (May 29, 2025), EXAS annual earnings before interest & taxes is -$1.00 billion, with the most recent change of -$826.86 million (-466.30%) on December 31, 2024.
  • During the last 3 years, EXAS annual EBIT has fallen by -$174.56 million (-21.04%).
  • EXAS annual EBIT is now -24873.56% below its all-time high of -$4.02 million, reached on December 31, 1998.

Performance

EXAS EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEXASincome statement metrics

quarterly EBIT:

-$92.17M+$775.55M(+89.38%)
March 31, 2025

Summary

  • As of today (May 29, 2025), EXAS quarterly earnings before interest & taxes is -$92.17 million, with the most recent change of +$775.55 million (+89.38%) on March 31, 2025.
  • Over the past year, EXAS quarterly EBIT has increased by +$9.62 million (+9.45%).
  • EXAS quarterly EBIT is now -1315.19% below its all-time high of $7.58 million, reached on September 30, 2023.

Performance

EXAS quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEXASincome statement metrics

TTM EBIT:

-$1.01B+$9.62M(+0.95%)
March 31, 2025

Summary

  • As of today (May 29, 2025), EXAS TTM earnings before interest & taxes is -$1.01 billion, with the most recent change of +$9.62 million (+0.95%) on March 31, 2025.
  • Over the past year, EXAS TTM EBIT has dropped by -$792.70 million (-369.59%).
  • EXAS TTM EBIT is now -16203.18% below its all-time high of -$6.18 million, reached on March 31, 2001.

Performance

EXAS TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEXASincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

EXAS EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-466.3%+9.4%-369.6%
3 y3 years-21.0%+48.9%-36.3%
5 y5 years-152.5%+30.8%-119.8%

EXAS EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-466.3%at low-1315.2%+89.4%-544.9%+0.9%
5 y5-year-466.3%at low-1315.2%+89.4%-544.9%+4.8%
alltimeall time<-9999.0%at low-1315.2%+89.4%<-9999.0%+4.8%

EXAS EBIT History

DateAnnualQuarterlyTTM
Mar 2025
-
-$92.17M(-89.4%)
-$1.01B(-0.9%)
Dec 2024
-$1.00B(+466.3%)
-$867.72M(+2876.2%)
-$1.02B(+427.1%)
Sep 2024
-
-$29.16M(+60.8%)
-$192.92M(+23.5%)
Jun 2024
-
-$18.13M(-82.2%)
-$156.18M(-27.2%)
Mar 2024
-
-$101.79M(+132.2%)
-$214.48M(+13.0%)
Dec 2023
-$177.32M(-71.3%)
-$43.84M(-678.0%)
-$189.78M(-30.2%)
Sep 2023
-
$7.58M(-109.9%)
-$271.90M(-36.4%)
Jun 2023
-
-$76.43M(-0.9%)
-$427.57M(-16.9%)
Mar 2023
-
-$77.10M(-38.8%)
-$514.45M(-16.7%)
Dec 2022
-$618.66M(-25.4%)
-$125.96M(-14.9%)
-$617.70M(-13.4%)
Sep 2022
-
-$148.09M(-9.3%)
-$713.38M(-2.7%)
Jun 2022
-
-$163.30M(-9.5%)
-$732.85M(-0.9%)
Mar 2022
-
-$180.35M(-18.6%)
-$739.21M(-10.9%)
Dec 2021
-$829.63M(+1.5%)
-$221.64M(+32.3%)
-$829.63M(-18.9%)
Sep 2021
-
-$167.56M(-1.2%)
-$1.02B(-3.3%)
Jun 2021
-
-$169.66M(-37.3%)
-$1.06B(+10.9%)
Mar 2021
-
-$270.77M(-34.8%)
-$953.93M(+16.9%)
Dec 2020
-$817.24M(+105.5%)
-$415.38M(+105.4%)
-$816.25M(+21.5%)
Sep 2020
-
-$202.25M(+208.7%)
-$671.75M(+35.2%)
Jun 2020
-
-$65.53M(-50.8%)
-$496.79M(+8.4%)
Mar 2020
-
-$133.09M(-50.9%)
-$458.14M(+15.2%)
Dec 2019
-$397.71M(+183.0%)
-$270.88M(+892.6%)
-$397.71M(+131.1%)
Sep 2019
-
-$27.29M(+1.5%)
-$172.10M(-4.1%)
Jun 2019
-
-$26.88M(-63.0%)
-$179.44M(-0.5%)
Mar 2019
-
-$72.66M(+60.5%)
-$180.35M(+28.3%)
Dec 2018
-$140.54M(+22.9%)
-$45.27M(+30.7%)
-$140.54M(+20.2%)
Sep 2018
-
-$34.63M(+24.6%)
-$116.94M(+6.9%)
Jun 2018
-
-$27.79M(-15.4%)
-$109.39M(-2.6%)
Mar 2018
-
-$32.85M(+51.6%)
-$112.34M(-1.8%)
Dec 2017
-$114.38M(-31.5%)
-$21.67M(-20.0%)
-$114.38M(-11.9%)
Sep 2017
-
-$27.08M(-11.9%)
-$129.83M(-7.6%)
Jun 2017
-
-$30.74M(-11.9%)
-$140.50M(-9.1%)
Mar 2017
-
-$34.90M(-6.0%)
-$154.49M(-7.5%)
Dec 2016
-$167.00M(+5.8%)
-$37.12M(-1.7%)
-$167.03M(-1.2%)
Sep 2016
-
-$37.75M(-15.6%)
-$169.09M(-3.1%)
Jun 2016
-
-$44.73M(-5.7%)
-$174.55M(+3.2%)
Mar 2016
-
-$47.44M(+21.1%)
-$169.20M(+7.4%)
Dec 2015
-$157.80M(+57.9%)
-$39.17M(-9.4%)
-$157.57M(+4.8%)
Sep 2015
-
-$43.21M(+9.7%)
-$150.42M(+7.9%)
Jun 2015
-
-$39.39M(+10.0%)
-$139.40M(+16.6%)
Mar 2015
-
-$35.81M(+11.8%)
-$119.55M(+19.7%)
Dec 2014
-$99.94M(+115.4%)
-$32.02M(-0.5%)
-$99.85M(+24.9%)
Sep 2014
-
-$32.19M(+64.7%)
-$79.92M(+35.7%)
Jun 2014
-
-$19.54M(+21.3%)
-$58.89M(+14.1%)
Mar 2014
-
-$16.11M(+33.3%)
-$51.62M(+11.5%)
Dec 2013
-$46.40M(-11.4%)
-$12.08M(+8.3%)
-$46.30M(-3.9%)
Sep 2013
-
-$11.16M(-9.0%)
-$48.17M(-3.5%)
Jun 2013
-
-$12.27M(+13.7%)
-$49.90M(-4.9%)
Mar 2013
-
-$10.79M(-22.7%)
-$52.47M(+0.4%)
Dec 2012
-$52.38M
-$13.95M(+8.2%)
-$52.28M(+8.8%)
DateAnnualQuarterlyTTM
Sep 2012
-
-$12.89M(-13.1%)
-$48.06M(+11.7%)
Jun 2012
-
-$14.84M(+40.0%)
-$43.01M(+23.5%)
Mar 2012
-
-$10.60M(+8.9%)
-$34.81M(+21.6%)
Dec 2011
-$28.62M(+148.7%)
-$9.73M(+24.1%)
-$28.62M(+27.8%)
Sep 2011
-
-$7.84M(+18.1%)
-$22.39M(+24.8%)
Jun 2011
-
-$6.64M(+50.9%)
-$17.94M(+30.2%)
Mar 2011
-
-$4.40M(+25.7%)
-$13.79M(+19.8%)
Dec 2010
-$11.51M(+24.4%)
-$3.50M(+3.2%)
-$11.51M(+16.7%)
Sep 2010
-
-$3.40M(+36.7%)
-$9.86M(+30.8%)
Jun 2010
-
-$2.48M(+17.0%)
-$7.54M(+0.5%)
Mar 2010
-
-$2.12M(+14.4%)
-$7.50M(-19.0%)
Dec 2009
-$9.25M(-1.3%)
-$1.85M(+72.4%)
-$9.25M(-2.0%)
Sep 2009
-
-$1.08M(-56.0%)
-$9.44M(-13.2%)
Jun 2009
-
-$2.44M(-37.0%)
-$10.88M(+4.0%)
Mar 2009
-
-$3.88M(+89.4%)
-$10.46M(+13.4%)
Dec 2008
-$9.37M(-19.7%)
-$2.05M(-18.5%)
-$9.22M(-16.3%)
Sep 2008
-
-$2.51M(+24.1%)
-$11.02M(-9.1%)
Jun 2008
-
-$2.02M(-23.5%)
-$12.13M(-0.3%)
Mar 2008
-
-$2.64M(-31.2%)
-$12.17M(+4.3%)
Dec 2007
-$11.67M(-13.5%)
-$3.84M(+6.2%)
-$11.67M(+18.1%)
Sep 2007
-
-$3.62M(+75.2%)
-$9.88M(+2.2%)
Jun 2007
-
-$2.06M(-3.8%)
-$9.67M(-13.4%)
Mar 2007
-
-$2.15M(+4.5%)
-$11.16M(-17.3%)
Dec 2006
-$13.50M(-10.1%)
-$2.05M(-39.7%)
-$13.50M(-6.6%)
Sep 2006
-
-$3.40M(-4.4%)
-$14.46M(-1.2%)
Jun 2006
-
-$3.56M(-20.6%)
-$14.63M(-4.3%)
Mar 2006
-
-$4.48M(+48.8%)
-$15.28M(+1.8%)
Dec 2005
-$15.01M(-21.8%)
-$3.01M(-15.8%)
-$15.01M(-10.4%)
Sep 2005
-
-$3.58M(-15.0%)
-$16.75M(-5.6%)
Jun 2005
-
-$4.21M(+0.2%)
-$17.75M(-1.3%)
Mar 2005
-
-$4.21M(-11.6%)
-$17.99M(-6.3%)
Dec 2004
-$19.20M(-33.4%)
-$4.75M(+3.8%)
-$19.20M(-5.2%)
Sep 2004
-
-$4.58M(+2.9%)
-$20.25M(-10.5%)
Jun 2004
-
-$4.45M(-17.7%)
-$22.64M(-13.6%)
Mar 2004
-
-$5.41M(-6.9%)
-$26.20M(-9.2%)
Dec 2003
-$28.84M(-6.5%)
-$5.81M(-16.5%)
-$28.84M(-4.6%)
Sep 2003
-
-$6.96M(-13.0%)
-$30.24M(-2.3%)
Jun 2003
-
-$8.01M(-0.5%)
-$30.94M(-0.3%)
Mar 2003
-
-$8.05M(+11.6%)
-$31.03M(+0.6%)
Dec 2002
-$30.84M(+17.7%)
-$7.21M(-5.9%)
-$30.84M(+0.2%)
Sep 2002
-
-$7.67M(-5.4%)
-$30.79M(+4.5%)
Jun 2002
-
-$8.11M(+3.1%)
-$29.48M(+5.7%)
Mar 2002
-
-$7.86M(+9.8%)
-$27.88M(+6.4%)
Dec 2001
-$26.20M(+158.2%)
-$7.16M(+12.7%)
-$26.20M(+37.6%)
Sep 2001
-
-$6.35M(-2.4%)
-$19.04M(+50.1%)
Jun 2001
-
-$6.51M(+5.4%)
-$12.69M(+105.4%)
Mar 2001
-
-$6.18M
-$6.18M
Dec 2000
-$10.15M(+92.8%)
-
-
Dec 1999
-$5.26M(+30.9%)
-
-
Dec 1998
-$4.02M
-
-

FAQ

  • What is Exact Sciences annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Exact Sciences?
  • What is Exact Sciences annual EBIT year-on-year change?
  • What is Exact Sciences quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Exact Sciences?
  • What is Exact Sciences quarterly EBIT year-on-year change?
  • What is Exact Sciences TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Exact Sciences?
  • What is Exact Sciences TTM EBIT year-on-year change?

What is Exact Sciences annual earnings before interest & taxes?

The current annual EBIT of EXAS is -$1.00B

What is the all time high annual EBIT for Exact Sciences?

Exact Sciences all-time high annual earnings before interest & taxes is -$4.02M

What is Exact Sciences annual EBIT year-on-year change?

Over the past year, EXAS annual earnings before interest & taxes has changed by -$826.86M (-466.30%)

What is Exact Sciences quarterly earnings before interest & taxes?

The current quarterly EBIT of EXAS is -$92.17M

What is the all time high quarterly EBIT for Exact Sciences?

Exact Sciences all-time high quarterly earnings before interest & taxes is $7.58M

What is Exact Sciences quarterly EBIT year-on-year change?

Over the past year, EXAS quarterly earnings before interest & taxes has changed by +$9.62M (+9.45%)

What is Exact Sciences TTM earnings before interest & taxes?

The current TTM EBIT of EXAS is -$1.01B

What is the all time high TTM EBIT for Exact Sciences?

Exact Sciences all-time high TTM earnings before interest & taxes is -$6.18M

What is Exact Sciences TTM EBIT year-on-year change?

Over the past year, EXAS TTM earnings before interest & taxes has changed by -$792.70M (-369.59%)
On this page